Ethyl 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl]acetate, 97%, 250mg

Methyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate, 95.0%, 500mg

Vinylphenyldimethylsilane, 95%, 25g

Sample vials ROTILABO® with short thread ND9 silanised, Clear glass, with solid conical base, 1.1 ml, 100 Piece(s)

1-[2-(2-fluorophenoxy)ethyl]-1H-indole-3-carbaldehyde, 95.0%, 5g

Quinoline-2,3-dicarboxylic acid, 95.0%, 100g

N-[(5-Chloro-3-oxido-1H-benzotriazol-1-yl)-4-morpholinylmethylene]-N-methylmethanaminium hexafluorophosphate, 98%, 5g

(S)-2-(2-(2-Aminoacetamido)acetamido)-4-methylpentanoic acid, 95.0%, 5g

(4R,4'R,5R,5'R)-2,2'-Diphenyl-[4,4'-bi(1,3-dioxane)]-5,5'-diol, 97%, 100mg

1,2,3,4-Tetrahydro-2-(trifluoroacetyl)isoquinoline-7-sulfonyl chloride, 98.0%, 1g

1-butyl-1H-pyrazol-5-amine, 95.0%, 1g

3-Methyl-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one, 98%, 250mg

BENZYL 3-(METHYLAMINO)AZETIDINE-1-CARBOXYLATE, 95.0%, 5g